TBK1 Gene Mutation clinical trials at UCSF

1 research study open to eligible people

The TBK1 gene mutation affects how cells in the body work. UCSF is looking for participants for a new clinical trial for this mutation. The trial will study how this mutation affects brain function over time. You can help researchers understand this gene mutation by joining the trial.

Showing trials for

  • ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

    open to eligible people ages 18 years and up

    ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

    San Francisco, California and other locations

Our lead scientists for TBK1 Gene Mutation research studies include .

Last updated: